Answer
Each vial of Tenkasi 400 mg (oritavancin diphosphate) powder for concentrate for solution for infusion is reconstituted aseptically with 40 mL of sterile water for injection; the resulting concentrate must then be diluted with glucose 5% before use.
Sources for this answer
- Tenkasi 400 mg powder for concentrate for solution for infusionA. Menarini Farmaceutica Internazionale SRL · emc · SmPC §6.6 Special precautions for disposal and other handling · Version 4Document updated
Sources checked